NCT04883255 Cannabis Use, Cognition, and the Endocannabinoid System in HIV Status RECRUITING Phase EARLY_PHASE1
NCT04880395 Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3 Status COMPLETED Phase PHASE4
NCT04860063 Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. Status UNKNOWN Phase PHASE3
NCT04770701 Protect and Improve Cluster of Differentiation 4 (CD4) Cells and B Cells Lymphocytes Status WITHDRAWN Phase PHASE4
NCT04738812 Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression Status COMPLETED Phase PHASE3
NCT04711265 Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys Status COMPLETED Phase N/A
NCT04661813 Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV Status COMPLETED Phase NA
NCT04620291 Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected Adults Status NOT_YET_RECRUITING Phase PHASE1
NCT04605354 Epidemiological and Clinical Description of Women Living With HIV in Selected Countries of Latin America Status UNKNOWN Phase N/A
NCT04596488 Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients Status COMPLETED Phase NA
NCT04568239 Impact of M184V on the Virological Efficacy to 3TC/DTG (LAMRES) Status COMPLETED Phase N/A
NCT04563962 Contingency Management for PrEP Adherence and/or Methamphetamine Use Status COMPLETED Phase NA
NCT04553081 2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial Status RECRUITING Phase PHASE4